Reverse Transcriptase Inhibitors [MoA]

Known as: Reverse Transcriptase Inhibitors 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2015
01219992015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Inhibitors that target the retroviral enzyme reverse transcriptase (RT) have played an indispensable role in the treatment and… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2011
2011
LINE-1s (L1, Long Interspersed Element-1) are the most abundant autonomous non-LTR retrotransposons in the human genome and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 2
Is this relevant?
2011
2011
Microbicides based on nonnucleoside reverse transcriptase inhibitors (NNRTIs) are currently being developed to protect women from… (More)
Is this relevant?
2001
2001
TSAO derivatives represent a class of nonnucleoside reverse transcriptase inhibitors (NNRTIs) that consistently select for the… (More)
Is this relevant?
Review
2000
Review
2000
  • W A O'brien
  • Clinical infectious diseases : an official…
  • 2000
The response to antiretroviral therapy in human immunodeficiency virus (HIV)-infected patients is limited by the emergence of… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
1999
1999
In an effort to obtain more insight into the interaction between HIV-1 reverse transcriptase and the alkenyldiarylmethanes (ADAMs… (More)
Is this relevant?